Basel, 6 - 8 October 2025
Schedule
Create your personal agenda –check the favourite icon
Oct 69:00
Conference pass
Oct 69:20
Conference pass
The In-Silico Slingshot: Redefining Drug Development in the Age of AI
Keynotes
As traditional R&D models strain under rising costs and declining ROI, the pharmaceutical industry stands at a tipping point. This keynote explores how in-silico methods—powered by AI, digital twins, and virtual trials—are transforming drug development from end to end, revolutionizing everything from pre-clinical safety studies and dose optimization to clinical trial design, regulatory submissions and post-marketing expansion.
We’ll explore the science, the systems, and the strategy behind this transformative shift. Attendees will gain insight into how organizations can embrace this paradigm, build future-ready capabilities, and lead in a data-driven, AI-enabled era of drug development.
Aaron Mitchell, Principal, ZS
Oct 611:40
Conference pass
Chair's remarks
AI in Drug Development and Discovery
Franck Augé, Director R&D Search and Evaluation AI and Digital Technologies, SERVIER
Oct 611:40
Conference pass
Chair's remarks
Cheminformatics
Werngard Czechtizky, Executive Director Head of Medicinal Chemistry, AstraZeneca
Oct 611:40
Conference pass
Oct 611:40
Conference pass
Chair's remarks
Big Data in Oncology
Oct 611:40
Conference pass
Chair's remarks
Digital Transformation
Angelika Fuchs, Chapter Lead Data Products and Platforms, Roche
Oct 611:40
Conference pass
Chair's remarks
Data Management, Storage and Architecture
Pierre Fischer, Product Line Lead Data Platforms, F. Hoffmann-La Roche Ltd
Oct 611:40
Conference pass
Chair's remarks
Data Integration + FAIR
Martin Romacker, Product Manager – Roche Data Marketplace, Roche
Oct 611:40
Conference pass
Chair's remarks
Analytics Platform
Stefan Schmitz, Head of Data Science Technology Enablement, Bayer AG
Oct 611:40
Conference pass
Chair's remarks
AI in Clinical Trials
Rana Abou Antoun, Global Commercial Director Cell and Gene, Novartis
Oct 611:45
Conference pass
Integrating and contextualizing multi-modal data for advancing personalized medicine
AI in Drug Development and Discovery
Carine Poussin, Head of AI for Life Sciences, CSEM
Oct 611:45
Conference pass
Predictive & Generative Modelling in Drug Design Opportunities and Challenges of Augmented Intelligence
Cheminformatics
Nils Weskamp, Associate Director Computational Chemistry / Data Science, Boehringer Ingelheim Pharma GmbH & Co. KG
Oct 611:45
Conference pass
AI immunology: a new era in vaccine discovery
Bioinformatics + In silico R&D
Andreas Holm Mattsson, Chief AI Officer, Evaxion Biotech
Oct 611:45
Conference pass
Upscaling for future pharma fit processes
Large Language Models
Carolina Benjaminsen, Senior Director and Head of Digital Science Academy for R&ED, Novo Nordisk
Oct 611:45
Conference pass
Machine learning and multi-modal data for target discovery and patient understanding
Big Data in Oncology
Sina Nassiri, Principal Bioinformatics Scientist, Roche Pharma
Oct 611:45
Conference pass
Bayer's Digital Transformation in R&D: what are the key catalysts
Digital Transformation
Claudia Vogt, Chief of Staff R&D Data Science & AI, Bayer AG
Oct 611:45
Conference pass
5 new ways to sabotage your R&D data platform
Data Management, Storage and Architecture
Maks Shah, Head Data Design Authority, Syngenta Crop Protection
Oct 611:45
Conference pass
Advanced meta data exchange for healthcare
Data Integration + FAIR
Steffen Vogler, Senior Imaging Technology Scientist, Bayer
Oct 611:45
Conference pass
Advanced gut-on-a-chip platform for therapeutic target identification
Analytics Platform
Paul Wilmes, Full Professor of Systems Ecology, University of Luxembourg
Oct 611:45
Conference pass
Eligibility Criteria Builder
AI in Clinical Trials
Shagun Grover, Product Lead - Study Design & Protocol Optimization, Roche
Oct 611:45
Conference pass
Real world evidence at a tertiary children’s hospital
Real World Evidence
Catherine Brownstein, Assistant Professor, Harvard Medical School
Oct 612:25
Conference pass
ML in drug discovery
AI in Drug Development and Discovery
Damian Roqueiro, Senior Scientist, Roche
Oct 612:25
Conference pass
Application of LLM in drug discovery
Cheminformatics
Werngard Czechtizky, Executive Director Head of Medicinal Chemistry, AstraZeneca
Oct 612:25
Conference pass
Event driven architecture for HT proteomics
Bioinformatics + In silico R&D
Francisco Bonachela Capdevila, TPO High Dimensional Biology and Bioinformatics,, JnJ
Oct 612:25
Conference pass
AI agents for translational medicine
Large Language Models
Oct 612:25
Conference pass
Identification of small molecules targeting rna
Big Data in Oncology
Antoine de Weck, Group Leader, Children's cancer Institute
Oct 612:25
Conference pass
Oct 612:25
Conference pass
FAIR In-vivo data Sharing: Enabling in-vivo workflows using a FAIR by design platform
Data Integration + FAIR
Anastasios Moresis, Principal Scientist Data Products and Platforms, Roche
Oct 612:25
Conference pass
Accelerating ML Deployment: Operationalizing Kubeflow for Scalable Drug Discovery at Roche
Analytics Platform
Malgorzata Bartosik, Senior IT Professional Data Science, Roche Polska Sp. Zoo
Oct 612:25
Conference pass
Boosting clinical data management with genAI
AI in Clinical Trials
Ercan Suekuer, Senior AI Clinical Data Scientist, Roche
Oct 612:25
Conference pass
RWE at UCB
Real World Evidence
Johann de Jong, Associate Director, Global Advanced Analytics, UCB Pharma
Oct 613:05
Conference pass
Early involvement of patients in clinical trials to develop innovative treatments (Gene Therapies)
AI in Drug Development and Discovery
Theodora Weisz, Head of Patient Advocacy and Public Affairs, Novartis Gene Therapies, Novartis Gene Therapies
Oct 613:05
Conference pass
The OpenChemLib: Powering Cheminformatics at Idorsia
Cheminformatics
Oct 613:05
Conference pass
Systems toxicology: leveraging in silico and bioinformatics potential in preclinical drug safety
Bioinformatics + In silico R&D
Oct 613:05
Conference pass
Power of LLMs in pre clinical drug discovery
Large Language Models
Shayoni Dutta, Data Science Manager, GlaxoSmithKline
Oct 613:05
Conference pass
Integrative longitudinal functional genomics To Identify Novel treatment Induced Cancer Vulnerabilities
Big Data in Oncology
Simon McDade, Professor of Functional Genomics, Queen's University Belfast
Oct 613:05
Conference pass
Digital transformation in bacteriology
Digital Transformation
Oct 613:05
Conference pass
Journey to democratise data: the good, the bad, the ugly
Data Management, Storage and Architecture
Pierre Fischer, Product Line Lead Data Platforms, F. Hoffmann-La Roche Ltd
Oct 613:05
Conference pass
Time Series Foundation Model (TSFM) for Forecasting in Pharma Supply Chain: Do they deliver?
Analytics Platform
Matias Callara, Senior Data Scientist, Roche
Oct 613:05
Conference pass
Digital twin for clinical trials
AI in Clinical Trials
Benjamin Gmeiner, Director and Head of Medical Data Strategy & Science, Novartis Pharma
Oct 613:05
Conference pass
AI in RWD
Real World Evidence
Abhishek Choudhary, Principal Data Engineer, Bayer AG
Oct 613:25
Conference pass
Networking Lunch
Keynotes
Anna Abiola, Senior Producer, Terrapinn Holdings Ltd
Oct 614:25
Conference pass
Chair's remarks
AI in Drug Development and Discovery
Caroline Gubser Keller, Global Head Data Science -Discovery Sciences, Novartis Biomedical Research
Oct 614:25
Conference pass
Chair's remarks
Cheminformatics
David Drake, Drug Discovery IT Capability Lead, Astrazeneca
Oct 614:25
Conference pass
Chair's remarks
Bioinformatics + In silico R&D
Derya Aytan-Aktug, Senior Bioinformatics Scientist, Leo Pharma
Oct 614:25
Conference pass
Oct 614:25
Conference pass
Chair's remarks
Big Data in Oncology
Oct 614:25
Conference pass
Chair's remarks
Digital Transformation
Oct 614:25
Conference pass
Chair's remarks
Data Management, Storage and Architecture
Pierre Fischer, Product Line Lead Data Platforms, F. Hoffmann-La Roche Ltd
Oct 614:25
Conference pass
Chair's remarks
Data Integration + FAIR
Martin Romacker, Product Manager – Roche Data Marketplace, Roche
Oct 614:25
Conference pass
Chair's remarks
Analytics Platform
Alfred Stefan, Manager LU Informatics, AbbVie
Oct 614:25
Conference pass
Oct 614:25
Conference pass
Chair's remarks
Real World Evidence
Shahed Iqbal, Executive Director and Head, Molecular Epidemiology, Biomarker Sciences, Gilead Sciences
Oct 614:30
Conference pass
Harnessing AI for Drug Discovery to Accelerate, Enhance, and Innovate
AI in Drug Development and Discovery
Caroline Gubser Keller, Global Head Data Science -Discovery Sciences, Novartis Biomedical Research
Oct 614:30
Conference pass
Drug Development Data Platform and In Silico R&D
Bioinformatics + In silico R&D
Echedey Lorenzo, Lead Data Engineer, Research Data Platform, AstraZeneca
Oct 614:30
Conference pass
The ”Majority Illusion” in DLBCL Lessons we have learned from social media help us identify cancer’s biomarkers
Big Data in Oncology
Luciano Cascione, Head of Bioinformatics Core Unit, Institute of oncology research (IOR),
Oct 614:30
Conference pass
KM enabled digital transformation
Digital Transformation
Joseph Pisari, Knowledge Management Team Lead, Novartis
Oct 614:30
Conference pass
Preparing biomedical research data landscape to be AI ready
Data Management, Storage and Architecture
Ralph Haffner, VP Research Informatics, Novartis, Biomedical Research
Oct 614:30
Conference pass
FAIR meta data management to accelerate data integration and insight generation
Data Integration + FAIR
Martin Romacker, Product Manager – Roche Data Marketplace, Roche
Oct 614:30
Conference pass
Operational simulation framework for internal programme modelling
Analytics Platform
Jin Hyun Ju, Director of Data Science, BridgeBio
Oct 614:30
Conference pass
How Federated Learning in AI can improve clinical trials quality
AI in Clinical Trials
Alessandro Raimondo, Business Development Manager, CERN
Oct 614:30
Conference pass
Oct 614:50
Conference pass
Improved disease protein prioritization from omics data through network embedding
Analytics Platform
Lars Juhl Jensen, Director, ZS
Oct 615:10
Conference pass
Generative Chemistry
AI in Drug Development and Discovery
Antoine Taly, Researcher, CNRS
Oct 615:10
Conference pass
Applying Predictive Modelling to Improve Early-Stage Drug Discovery
Cheminformatics
Prakash Rathi, Director, R&DIT, Data Analytics and AI, AstraZeneca
Oct 615:10
Conference pass
In silico darpin therapeutics
Bioinformatics + In silico R&D
Ana Filipa Fonseca, Director, Global RLT Strategy & Early Portfolio, Novartis
Oct 615:10
Conference pass
LLMs across pharma value chain
Large Language Models
Waheed Jowiya, Digitalisation Strategy Lead, Novo Nordisk
Louise Lind Skov, Director of Content Digitalisation, Novo Nordisk
Oct 615:10
Conference pass
Accelerating clinical trials using AI
Big Data in Oncology
Oct 615:10
Conference pass
Digital services with medical products
Digital Transformation
Oct 615:10
Conference pass
Navigating the Data Fabric: Debiopharm's Journey to Mastering Clinical and Pre-Clinical Data
Data Management, Storage and Architecture
Frederico Braga, Head of Digital and IT, Debiopharm
Oct 615:10
Conference pass
Sharing antiviral discovery data to accelerate therapeutic discovery
Data Integration + FAIR
Oct 615:10
Conference pass
The shift of Analytics Platforms and organizations in light of AI
Analytics Platform
Oct 615:10
Conference pass
Generative AI & the Importance of Having a Well Crafted Data Strategy
AI in Clinical Trials
Oct 615:10
Conference pass
Impact of RWE in cannabinoids based medicines
Real World Evidence
Ana Serrato, Head Clinical Development, Avextra
Oct 615:50
Conference pass
Agents to connect all the dots
AI in Drug Development and Discovery
Dennis Madsen, Scientific Director, Novo Nordisk A/S
Oct 615:50
Conference pass
Data driven approach to Targeted glues drug discovery
Bioinformatics + In silico R&D
Liliana Greger, Senior Director of Bioinformatics, Amphista Therapeutics
Oct 615:50
Conference pass
LLMs at Bayer
Large Language Models
Jordi Casanellas, Head of Language AI, Bayer
Oct 615:50
Conference pass
Translating Big Data in Oncology for Clinical Benefit: Unlocking Insights for Better Patient Outcomes
Big Data in Oncology
Anne Zuse, Clinical Scientist Associate Director, Novartis
Oct 615:50
Conference pass
Digital transformation & Pharma GTM model
Digital Transformation
Barbara Albientz, Chief Commercial Officer, Helvion Pharma
Oct 615:50
Conference pass
Transform genomic and biological data into insights
Data Management, Storage and Architecture
Kortine Kleinheinz, Digital Lead for Research IT, Bayer AG
Oct 615:50
Conference pass
Swiss personalised health network
Data Integration + FAIR
Sabine Österle, Lead Sematic Interoperability Strategy and FAIR Data Team, SIB Swiss Institute of Bioinformatics
Oct 615:50
Conference pass
Building a group wide-data platform
Analytics Platform
Christophe Chabbert, Group Lead, Data & AI, Octapharma Biopharmaceuticals GmbH
Oct 615:50
Conference pass
Machine learning algorithms as trial endpoints
AI in Clinical Trials
Martin de Borst, Nephrologist and Professor of Medicine, University Medical Centre Groningen
Oct 615:50
Conference pass
NHS secured data environments for RWE generation
Real World Evidence
Adrian Jonas, Chief Analyst for the North West Region, NHS
Oct 616:10
Conference pass
Networking Break
Keynotes
Anna Abiola, Senior Producer, Terrapinn Holdings Ltd
Oct 616:40
Conference pass
Chair's remarks
AI in Drug Development and Discovery
John Wise, Consultant, Pistoia Alliance
Oct 616:40
Conference pass
Chair's remarks
Cheminformatics
Nils Weskamp, Associate Director Computational Chemistry / Data Science, Boehringer Ingelheim Pharma GmbH & Co. KG
Oct 616:40
Conference pass
Chair's remarks
Bioinformatics + In silico R&D
Werngard Czechtizky, Executive Director Head of Medicinal Chemistry, AstraZeneca
Oct 616:40
Conference pass
Oct 616:40
Conference pass
Chair's remarks
Big Data in Oncology
Crina Samarghitean, Medical Doctor, Tampere University
Oct 616:40
Conference pass
Chair's remarks
Digital Transformation
Oct 616:40
Conference pass
Chair's remarks
Data Management, Storage and Architecture
Pierre Fischer, Product Line Lead Data Platforms, F. Hoffmann-La Roche Ltd
Oct 616:40
Conference pass
Chair's remarks
Data Integration + FAIR
Martin Romacker, Product Manager – Roche Data Marketplace, Roche
Oct 616:40
Conference pass
Oct 616:40
Conference pass
Chair's remarks
Real World Evidence
Neehar Kundurti, Faculty, tulane university school of medicine
Oct 616:45
Conference pass
Applied AI use cases in drug discovery and development
AI in Drug Development and Discovery
Anna Fournier, Principal Data Scientist, Swiss Data Science Center
Oct 616:45
Conference pass
Chemistry with Artificial Intelligence
Cheminformatics
Rolf Jautelat, VP R&D Data Science & AI, Bayer
Oct 616:45
Conference pass
Computational approaches for target discovery
Bioinformatics + In silico R&D
Becky Saunders, Associate Director, Computational Biologist, E-therapeutics
Oct 616:45
Conference pass
How we utilise generative AI at Novo Nordisk
Large Language Models
Peter Vester, Lead Data Scientist, Novo Nordisk
Oct 616:45
Conference pass
Unlocking biomedical big data for precision oncology with privacy-enhancing technologies
Big Data in Oncology
Sandra Barbosu, Associate Director, Information Technology and Innovation Foundation
Oct 616:45
Conference pass
Digital Transformation in pharmaceutical Manufacturing
Digital Transformation
Frank Thielmann, Head Function of the Future, Takeda
Oct 616:45
Conference pass
Data products and data marketplace success stories
Data Management, Storage and Architecture
Gaurav Grigo, Sr. Director, Head of Architecture & Systems Engineering, DDIT-R&ED, Novo Nordisk
Sandeep Majumder, Head of Data Management and Solutions, Novo Nordisk
Oct 616:45
Conference pass
Drug Development Data Platform and Data Integration + FAIR
Data Integration + FAIR
Ander Sainz Loyola, Lead Data Engineer, Research Data Platform, Astrazeneca
Oct 616:45
Conference pass
Microbial Genomics platform
Analytics Platform
Tim Roloff, Co Department Head Microbial Genomics, University of Zurich
Oct 616:45
Conference pass
Transforming Clinical Research with AI Agents
AI in Clinical Trials
Georgios Kavousanos, Senior AI Engineer, Novo Nordisk
Oct 616:45
Conference pass
AI agents for Evidence Generation
Real World Evidence
Thirupathi Pattipaka, Global Director, Data Science and AI, Novartis
Oct 617:05
Conference pass
(Cell) Painting by Numbers: Analysis Pipelines for Phenotypic Screening in Early Drug Discovery
Bioinformatics + In silico R&D
Alithea Genomics is a global leader in scalable transcriptomics solutions for screening applications.We support pharmaceutical, biotech, and agrochemical companies in accelerating and de-risking their compound selection processes.
Our proprietary high-throughput and ultra-low-cost RNA-seq library preparation technology (DRUG-seq) allows for transcriptomic data generation from thousands of samples in a streamlined and convenient workflow.
Our protocol requires no RNA extraction and has been validated on multiple cell lines. On the analysis side, we provide default upstream, downstream, and QC analysis, along with customized solutions from our team of expert bioinformaticians.Beyond library prep, sequencing, and data analysis, we also offer end-to-end, high-throughput cell culture, treatment, and imaging services (including cell painting).
Oct 617:05
Conference pass
ELaiN – the AI Scientific Assistant. How quickly they grow up
Digital Transformation
Rob will discuss the significant advancements in ELaiN, an AI-driven digital assistant designed to create experiment content and perform advanced scientific searches. He will highlight the remarkable progress that has been made and how ELaiN has evolved since the Lab of the Future Conference 2024.
For those that want to meet ELaiN already?https://www.sapiosciences.com/blog/sapio-elain-your-science-aware-ai-lab-assistant/
Oct 617:25
Conference pass
From Data to Diagnosis: The Power of Multi-Omics in Clinical Research
Bioinformatics + In silico R&D
Moderator: Ornella Cominetti, Senior Omics Data Specialist, Nestlé
Nerses Shahbazyan, Bioinformatics Scientist, Yerevan State Medical University
Silvia Ramirez, Global Digital Precision Healthcare Director, Astrazeneca
Oct 617:25
Conference pass
Are LLMs enough?
Large Language Models
Michele Siccardi, Executive Director, International Insights & Analytics (I&A), CSL Behring
Lee Clewley, VP, AI & Informatics, e-therapeutics plc
Oct 617:25
Conference pass
Using multi-modal patient level data in discovery and early development
Big Data in Oncology
Moderator: Shahed Iqbal, Executive Director and Head, Molecular Epidemiology, Biomarker Sciences, Gilead Sciences
Jake Chen, Endowed Professor and Founding Director, SPARC, University of Alabama at Birmingham
Dan Crowley, Chief Executive Officer, RemedyBio
Priyasma Bhoumik, Strategic Vendor Manager, PS AI Strategy Lead, Roche
Oct 617:25
Conference pass
Health Data Governance in the light of the new EU regulations
Data Management, Storage and Architecture
Moderator: Nicola Orlandi, Global Head of Data Privacy, Bausch & Lomb
Angela Mazzonetto, Chief Privacy Officer, Bruker
Pascal Hofer, Head of Legal Digital & IT, F. Hoffmann-La Roche AG
Gaurav Grigo, Sr. Director, Head of Architecture & Systems Engineering, DDIT-R&ED, Novo Nordisk
Oct 617:25
Conference pass
Turning Data into Action: Integrating Processes Analytically
Analytics Platform
Moderator: Francesco Orsi, Data Science Manager, Roche
Raul Mora, Senior Development Excellence Lead, Roche
Parag Dave, Head of Data, Digital, and Technology, Takeda
Andres Buser, Chapter Lead New Modality IP, F. Hoffmann - La Roche AG
Oct 617:25
Conference pass
Digital Twins in Drug Development: Accelerating Clinical Trial Timelines
AI in Clinical Trials
Moderator: Mara Hummel, Sr Clinical Operations Lead, Hoffmann-La Roche Ltd.
Mateus Patricio, Director Data Analytics & AI Engineering, Astrazeneca
Christian Eisen, Director Translational Science, AstraZeneca
Benjamin Gmeiner, Director and Head of Medical Data Strategy & Science, Novartis Pharma
Oct 617:25
Conference pass
Elevate health – improving patient care
Real World Evidence
Moderator: Petra Nathan, Global Head of Implementation Science, Boehringer Ingelheim
Michael Rebhan, Associate Director, Translational Research DS, Novartis
Manuela Maronati, Head of Rare Diseases Europe, UCB
Theodora Weisz, Head of Patient Advocacy and Public Affairs, Novartis Gene Therapies, Novartis Gene Therapies
Oct 618:05
Conference pass
Networking Drinks Reception
Keynotes
Anna Abiola, Senior Producer, Terrapinn Holdings Ltd
Create your personal agenda –check the favourite icon
Oct 79:05
Conference pass
Keynote Presentation
Keynotes
Etienne Delille, SVP, Global Chief Digital Information Officer, Ipsen
Oct 711:45
Conference pass
Chair's remarks
Bioinformatics + In silico R&D
Simon McDade, Professor of Functional Genomics, Queen's University Belfast
Oct 711:45
Conference pass
Oct 711:45
Conference pass
Chair's remarks
Large Language Models
Tankred Ott, Senior Data Scientist, Novo Nordisk
Oct 711:45
Conference pass
Chair's remarks
Digital Transformation
Maya Shevlyakova, Associate Director Global Digital Core, CSL Behring AG
Oct 711:45
Conference pass
Chair's remarks
Data Integration + FAIR
Oct 711:45
Conference pass
Chair's remarks
AI in Clinical Trials
Raul Mora, Senior Development Excellence Lead, Roche
Oct 711:45
Conference pass
Oct 711:45
Conference pass
Oct 711:50
Conference pass
Accelerating drug discovery for large molecules using AI ready data platforms
AI in Drug Development and Discovery
Sabyasachi Dasgupta, Global Head of R&D Data Platforms & Products, Sanofi
Oct 711:50
Conference pass
Discovery and engineering of next-gen immunotherapies with EMLy Co-pilot
Bioinformatics + In silico R&D
Jacob Hurst, Chief Technology Officer, Etcembly
Oct 711:50
Conference pass
LLMs and knowledge graphs
Large Language Models
Tankred Ott, Senior Data Scientist, Novo Nordisk
Oct 711:50
Conference pass
Realising value of digital transformation a real-world example
Digital Transformation
Inger Nielsen, Team lead, Digitalisation, Novo Nordisk
Oct 711:50
Conference pass
Before Gen AI, Get Your Data Right: Why FAIR Data Matters
Data Integration + FAIR
Oct 711:50
Conference pass
R&D analytics at your fingertips: the CSL scientific app store
Analytics Platform
Carmen Weber, Manager Data Excellence, CSL Behring
Oct 711:50
Conference pass
AI driven trial design and trial planning
AI in Clinical Trials
Jeremy Zhang, Sr Director, Advanced Analytics, Gilead Sciences
Oct 711:50
Conference pass
AI for RWE
Real World Evidence
Oct 711:50
Conference pass
Foundational model for medical imaging
Image Analysis
Sadegh Mohammadi, Head of Computer Vision & Sound Analysis, Bayer AG
Oct 712:10
Conference pass
Sponsor -SAS
Large Language Models
José Miguel Fernández Pueyo, Biostatistics Manager, SGS - Pharma
Wesley Wuyts, Sr systems engineer, SAS
Oct 712:30
Conference pass
Deciphering immune landscape with AI
AI in Drug Development and Discovery
Oct 712:30
Conference pass
DigiMab: in-silico Antibody Discovery Platform
Bioinformatics + In silico R&D
Irem Nasir, R&D Engagement Lead, Sr. Data Scientist, Bayer
Oct 712:30
Conference pass
Integrating Single-Cell Multi-Omics into Clinical Trials: Paving the Way for Precision Medicine and Biomarker Discovery
Single Cell Genomics
Vivek Das, Lead Data Scientist, AI and Analytics, Novo Nordisk
Oct 712:30
Conference pass
Language of biology: using LLMs for drug target discovery
Large Language Models
Michal Pikusa, Associate Director and Senior Principal Data Scientist, Novartis
Oct 712:30
Conference pass
Increasing operational efficiencies: Driving Digital Adoption with Product Analytics
Digital Transformation
Liselle Mulcaire, Digital Product Operations, Development Digital Transformation, Novo Nordisk
Oct 712:30
Conference pass
Big Data in FAIR implementation from an international perspective
Data Integration + FAIR
Zisis Kozlakidis, Head of Laboratory Services and Biobanking, World Health Organization / International Agency For Research on Cancer
Oct 712:30
Conference pass
Data Science under One Roof OCEAN & NextGen @ Roche PD Data Sciences
Analytics Platform
Helene Royo, Senior Principal Data Science Product Leader, Roche
Oct 712:30
Conference pass
iQNow AI enabled approach to knowledge management
AI in Clinical Trials
Oct 712:30
Conference pass
Elevate health open science initiative
Real World Evidence
Michael Rebhan, Associate Director, Translational Research DS, Novartis
Oct 712:30
Conference pass
Image analysis in cryoEM to rationalise drug discovery
Image Analysis
Alexey Rak, Department Head, Bio Structure and Biophysics Integrated Drug Discovery,, SANOFI
Oct 713:10
Conference pass
Genomeasia 100K
Population Genomics
Hie Lim Kim, Assistant Professor, Asian School of Environment, NTU Singapore
Oct 713:10
Conference pass
Utilising multimodal data in early drug development
AI in Drug Development and Discovery
Matthias Orlowski, Principal ML Engineer, Bayer AG
Oct 713:10
Conference pass
Early target assessment
Bioinformatics + In silico R&D
Oct 713:10
Conference pass
Single cell barcoding technology to design treatment for ovarian cancer
Single Cell Genomics
Oct 713:10
Conference pass
Exploring the Future of Preclinical Research: Our AI Chatbot for Data Annotation, Retrieval and Writing Assistance
Large Language Models
Annika Kreuchwig, Senior Data Scientist, Bayer
Oct 713:10
Conference pass
The next steps towards customer centricity
Digital Transformation
Michael Zaiac, Head of Medical Affairs Oncology Europe and Canada, Daiichi Sankyo
Oct 713:10
Conference pass
FAIR Knowledge Graphs, benefits and challenges
Data Integration + FAIR
Oct 713:10
Conference pass
Sevier’s analytics platform
Analytics Platform
Thibaut Snollaerts, Senior Manager, Pre-clinical Data Management, SERVIER
Oct 713:10
Conference pass
Enhancing Drug Development: The Role of Digital Biomarkers in Clinical Trials
AI in Clinical Trials
Thanneer Perumal, Senior Principal Scientist, Roche
Oct 713:10
Conference pass
Evidence generation in early-stage drug development
Real World Evidence
Moritz Saxenhofer, Senior Manager Translational Research, CSL Behring
Oct 713:10
Conference pass
Phenomic immune-health profiling through self-supervised representation learning
Image Analysis
Oct 713:30
Conference pass
Networking Lunch
Keynotes
Anna Abiola, Senior Producer, Terrapinn Holdings Ltd
Oct 714:30
Conference pass
Chair's remarks
AI in Drug Development and Discovery
Giovanni Rizzo, Partner Biotech Fund, Indaco Venture Partners
Oct 714:30
Conference pass
Chair's remarks
Bioinformatics + In silico R&D
Simon McDade, Professor of Functional Genomics, Queen's University Belfast
Oct 714:30
Conference pass
Chair's remarks
Single Cell Genomics
Zhongyi Wang, Senior Expert II Data Science, Novartis
Oct 714:30
Conference pass
Chair's remarks
Large Language Models
Jake Chen, Endowed Professor and Founding Director, SPARC, University of Alabama at Birmingham
Oct 714:30
Conference pass
Oct 714:30
Conference pass
Chair's remarks
Data Integration + FAIR
Andrea Possenti, Associate Principal Data Scientist, AstraZeneca
Oct 714:30
Conference pass
Chair's remarks
Analytics Platform
Alfred Stefan, Manager LU Informatics, AbbVie
Oct 714:30
Conference pass
Chair's remarks
AI in Clinical Trials
Raul Mora, Senior Development Excellence Lead, Roche
Oct 714:30
Conference pass
Chair's remarks
Real World Evidence
Diar Fattah, Global Director, Innovative Value Strategies And Evidence (Respiratory), AstraZeneca
Oct 714:30
Conference pass
Chair's remarks
Image Analysis
Steffen Vogler, Senior Imaging Technology Scientist, Bayer
Oct 714:35
Conference pass
How to optimize AI quality methods to utilize prior knowledge
AI in Drug Development and Discovery
Etzard Stolte, Global Head Of Knowledge Management Ptd, Roche
Oct 714:35
Conference pass
Sabah Nature Wonders: For Sustainable Drug Development
Bioinformatics + In silico R&D
Syahriel Abdullah, Senior Lecturer / Researcher, Universiti Malaysia Sabah (UMS)
Oct 714:35
Conference pass
Leveraging single cell and spatial transcriptomics for target discovery
Single Cell Genomics
Zhongyi Wang, Senior Expert II Data Science, Novartis
Oct 714:35
Conference pass
Building an AI Agent on top of small language models to automate Molecular Dynamics simulations
Large Language Models
Guglielmo Iozzia, Director – Machine Learning/AI and Applied Mathematics, MSD
Oct 714:35
Conference pass
Oct 714:35
Conference pass
Bridging the gap; academic insights to regulatory approvals
Data Integration + FAIR
Elena Zhuravleva, Global Medical Science Leader, Oncology, Roche
Oct 714:35
Conference pass
Advancing OCT Analysis in nAMD and DR/DME Treatment
Analytics Platform
Christina Pamela Kreutzmann, Global AI Deployment Lead, Roche
Oct 714:35
Conference pass
In silico trials
AI in Clinical Trials
Oct 714:35
Conference pass
Cross functional use of RWE
Real World Evidence
Diar Fattah, Global Director, Innovative Value Strategies And Evidence (Respiratory), AstraZeneca
Oct 714:55
Conference pass
Bring Data to Life, Generating Value from AI in Clinical Trials
AI in Clinical Trials
Tankred Ott, Senior Data Scientist, Novo Nordisk
Nanna Holmstrup, Program Director, Novo Nordisk
Oct 715:15
Conference pass
Revolutionising Drug Discovery: AI-Powered Identification of Therapeutic Targets
AI in Drug Development and Discovery
Lee Clewley, VP, AI & Informatics, e-therapeutics plc
Oct 715:15
Conference pass
AI for automatic Parkinson’s Disease Voice Assessment
Bioinformatics + In silico R&D
Parvaneh Janbakhshi, Data Scientist, Bayer
Oct 715:15
Conference pass
Decoding the regulatory genome through multi-omics integration to identify novel non-coding RNA targets
Single Cell Genomics
Oct 715:15
Conference pass
LLMs at Roche
Large Language Models
Bruno Gagliano, Expert Data Scientist, Roche
Oct 715:15
Conference pass
Reimagining Preclinical Systems: Leveraging GenAI and Knowledge Graph Techniques
Digital Transformation
Jobst Loeffler, Product Owner, Bayer
Oct 715:15
Conference pass
Empowering data science across functions with reusable modules
Analytics Platform
Philip Gebus, Principal AI Engineer, Bayer
Oct 715:15
Conference pass
An AI powered “neural system” that enriches operational decisions in Clinical Development
AI in Clinical Trials
Guillaume Carbonneau, Vice President, Operational Data Insights, Novo Nordisk
Abhishek Chatterjee, Head of Product Suite, Senior Director, Novo Nordisk
Nicklas Walldorf Gaardsted, Director, Head of Data & Modelling, Novo Nordisk
Oct 715:15
Conference pass
Simplify and accelerate access to RWD through AI
Real World Evidence
Leonardo D'Ambrosi, Principal Data Scientist, Bayer Pharma AG
Oct 715:15
Conference pass
Electron microscopy imaging and analysis for biotech and pharma R&D
Image Analysis
Andrzej Rzepiela, Lead Data Scientist, ETH
Oct 715:35
Conference pass
Broadening precision medicine through pharmacogenomics
Population Genomics
Oct 715:35
Conference pass
Unlocking the potential of hERVs as vaccine antigens
AI in Clinical Trials
Christian Garde, Director of Bioinformatics, Evaxion Biotech
Oct 715:55
Conference pass
Exploratory rare variant analysis in neurodegeneration using AI within UK Biobank and clinical trials
Population Genomics
Achim Kless, Senior Director Pain Genetics, Eli Lilly and Company
Oct 715:55
Conference pass
Implementing AI in Servier therapeutic projects
AI in Drug Development and Discovery
Francois-Xavier Blaudin de Thé, Therapeutic lead Data Digital and AI, SERVIER
Oct 715:55
Conference pass
Colorectal cancer liver metastasis subtypes and their trajectory
Bioinformatics + In silico R&D
Nerses Shahbazyan, Bioinformatics Scientist, Yerevan State Medical University
Oct 715:55
Conference pass
LLMs at the University of Zurich
Large Language Models
Ana Kotarcic, Researcher, NLP and Deep Learning, University of Zurich
Oct 715:55
Conference pass
How we apply behaviour science for transformation implication and cost efficiency
Digital Transformation
Oct 715:55
Conference pass
Data Integration + FAIR from a Roche perspective
Data Integration + FAIR
Roman Engel, Head Agile Document Flow - VPH, Roche
Oct 715:55
Conference pass
AI augmented analytics platforms in peptide optimisation
Analytics Platform
Andrea Possenti, Associate Principal Data Scientist, AstraZeneca
Oct 715:55
Conference pass
High uncertainty Decision making enabled by machine learning models
AI in Clinical Trials
Raul Mora, Senior Development Excellence Lead, Roche
Oct 715:55
Conference pass
simulations of the patient journey in CVD within the real world data sections.
Real World Evidence
Janne Martikainen, Professor (pharmacoeconomics), University of Eastern Finland
Oct 715:55
Conference pass
Revolutionizing Vascular Diagnostics: AI-Enhanced Flow Prediction from Static Medical Images
Image Analysis
Oct 716:05
Conference pass
Networking Break
Keynotes
Anna Abiola, Senior Producer, Terrapinn Holdings Ltd
Oct 716:45
Conference pass
Chair's remarks
AI in Drug Development and Discovery
Giovanni Rizzo, Partner Biotech Fund, Indaco Venture Partners
Oct 716:45
Conference pass
Chair's remarks
Large Language Models
Peter Vester, Lead Data Scientist, Novo Nordisk
Oct 716:45
Conference pass
Chair's remarks
Digital Transformation
Angelika Fuchs, Chapter Lead Data Products and Platforms, Roche
Oct 716:45
Conference pass
Chair's remarks
Data Integration + FAIR
Raed Haltam, Product Manager, Hofmann La Roche
Oct 716:45
Conference pass
Chair's remarks
Real World Evidence
Diar Fattah, Global Director, Innovative Value Strategies And Evidence (Respiratory), AstraZeneca
Oct 716:45
Conference pass
Chair's remarks
Image Analysis
Steffen Vogler, Senior Imaging Technology Scientist, Bayer
Oct 716:50
Conference pass
Developing Integrated Risk Scores for Cardiovascular Disease Prediction
Population Genomics
Panagiotis Deloukas, Director of William Harvey Institute,, Queen Mary University of London
Oct 716:50
Conference pass
Omics based off target prediction
Bioinformatics + In silico R&D
Beatriz Roson, Director, Bioinformatics, Astrazeneca
Oct 716:50
Conference pass
Real Value with GenAI in clinical Development
Large Language Models
Daryna Smyrnova, AI Lead for Clinical Development, UCB
Oct 716:50
Conference pass
Increasing engagement with digital health
Digital Transformation
Thomas Boillat, Senior Digital Health Product Lead, Roche
Oct 716:50
Conference pass
Insights in early stage developments
Data Integration + FAIR
Valentina Ranghetti, Customer Insights Lead, Roche
Oct 716:50
Conference pass
Servier’s Analytics Platform: Accelerating Science
Analytics Platform
Yannick Haudry, Lead Data Platform Product Manager, Servier
Oct 716:50
Conference pass
Next level knowledge management in clinical trials
AI in Clinical Trials
Nicola Goetz, Expert Clinical Data Engineer, Boehringer Ingelheim Pharma GmbH & Co KG
Oct 716:50
Conference pass
The World After the 23&Me Hangover: Four Pillars to Rebuild Precision Medicine From the Patient Up
Real World Evidence
Alessandro Riccombeni, CEO, Axia Medicine
Oct 716:50
Conference pass
Computation pathology in oncology drug development
Image Analysis
Christian Eisen, Director Translational Science, AstraZeneca
Oct 717:10
Conference pass
Innovative trial Design powered by Agentic AI & connected Insights
AI in Clinical Trials
Abhishek Chatterjee, Head of Product Suite, Senior Director, Novo Nordisk
Oct 717:30
Conference pass
Summary Panel Population Genomics
Population Genomics
Moderator: Jens Habermann, Director General, BBMRI-ERIC
Oct 717:30
Conference pass
The Road Map to Transitioning from Ad-hoc AI to Business Value Generating AI
AI in Drug Development and Discovery
Moderator: Carmen Miguel, Legal Director, Data Privacy, Alnylam
Jeff Milton, Chief Executive Officer, La Jolla Labs
Frederico Braga, Head of Digital and IT, Debiopharm
Raul Mora, Senior Development Excellence Lead, Roche
Oct 717:30
Conference pass
Women in leadership
Bioinformatics + In silico R&D
Irem Nasir, R&D Engagement Lead, Sr. Data Scientist, Bayer
Oct 717:30
Conference pass
Challenges in validating the many in silico targets now being generated by AI
Single Cell Genomics
Moderator: Dan Crowley, Chief Executive Officer, RemedyBio
Jake Chen, Endowed Professor and Founding Director, SPARC, University of Alabama at Birmingham
Werngard Czechtizky, Executive Director Head of Medicinal Chemistry, AstraZeneca
Oct 717:30
Conference pass
AI Agents, the future of LLMs?
Large Language Models
Michael Schorpp, Head of Knowledge Management and AI, Boehringer Ingelheim International GmbH
Gregory Ryslik, CTO, Compass Pathways
Oct 717:30
Conference pass
The Impact of Digital Transformation on Product Delivery in Healthcare
Digital Transformation
Michele Siccardi, Executive Director, International Insights & Analytics (I&A), CSL Behring
Moderator: Anastassia Anastassopoulou, Advanced Analytics Strategy Director, Daiichii Sankyo Europe
Monika Trehan, M&A Lead Europe, Dr Reddys
Bárbara Fernandes de Souza, Digital Operations Specialist, CSL Behring
Oct 717:30
Conference pass
Master Data Management at AstraZeneca
Data Integration + FAIR
Habib Baghirov, Associate Director, AstraZeneca
Oct 717:30
Conference pass
Multi-modal AI in precision medicine education
Analytics Platform
Moderator: Neehar Kundurti, Faculty, tulane university school of medicine
Priyasma Bhoumik, Strategic Vendor Manager, PS AI Strategy Lead, Roche
Oct 717:30
Conference pass
The impact of AI on clinical trials within clinical development
AI in Clinical Trials
Moderator: Pascal Bouquet, Managing Partner, HealthTechPartners 42
Marion Legler, Head of Decision Science & AI, Bayer
Vincent Lepreux, Investment Director, Debiopharm Innovation Fund
Guillaume Carbonneau, Vice President, Operational Data Insights, Novo Nordisk
Oct 717:30
Conference pass
Adoption of Real-World Data and Real-World Evidence in regulatory decision-making
Real World Evidence
Moderator: Vassilis Bitsikas, Translational Data Science, Novartis
Crina Samarghitean, Medical Doctor, Tampere University
Oct 717:30
Conference pass
Unravelling the Impact of AI and Machine Learning in Image Analysis: Advancements, Challenges, and Future Directions in Pharma and Healthcare Industries
Image Analysis
Moderator: Andrzej Rzepiela, Lead Data Scientist, ETH
Oct 717:50
Conference pass
Ontologies in clinical trials using AI
Data Integration + FAIR
Raed Haltam, Product Manager, Hofmann La Roche
Oct 718:10
Conference pass
Networking Drinks Reception
Keynotes
Anna Abiola, Senior Producer, Terrapinn Holdings Ltd
Create your personal agenda –check the favourite icon
Oct 89:00
Conference pass
Chair's remarks
Keynotes
Joerg Degen, VP & Head of Computational Medicine, Roche
Oct 89:05
Conference pass
Personalised medicine through pharmacogenomics - making care safer, more effective and cost effective
Keynotes
Oct 89:25
Conference pass
Investor Panel: Backing the AI-Biology Frontier: Where Top Investors Are Placing Bets
Keynotes
Moderator: Rana Lonnen, General Partner, Science Capital Ventures
Lana Ghanem, Managing Director, Hikma Ventures/VP of Digital Health & Life Sciences Investements, Hikma Pharmaceuticals
Oct 811:05
Conference pass
Chair's remarks
AI in Drug Development and Discovery
Werngard Czechtizky, Executive Director Head of Medicinal Chemistry, AstraZeneca
Oct 811:05
Conference pass
Chair's remarks
Bioinformatics + In silico R&D
Oct 811:05
Conference pass
Chair's remarks
Large Language Models
Shawn Kyzer, Director, R&D IT - Data, Analytics & AI, Engineering, Astrazeneca
Oct 811:05
Conference pass
Chair's remarks
Digital Transformation
Syed Ali Shirazi, Head of Smart Factory, SANOFI
Oct 811:05
Conference pass
Oct 811:05
Conference pass
Chair's remarks
Real World Evidence
Matthias Hartung, Data & AI Expert, Boehringer Ingelheim Pharma GmbH
Oct 811:05
Conference pass
Chair's remarks
Precision Medicine, Diagnostics and Therapies
Maria Guerrero, EMEA Product manager, Janssen
Oct 811:05
Conference pass
Chair's remarks
Lab Automation
Parag Dave, Head of Data, Digital, and Technology, Takeda
Oct 811:05
Conference pass
Chair's remarks
Quantum Pharma
John Wise, Consultant, Pistoia Alliance
Oct 811:05
Conference pass
Chair's remarks
Start up and innovation
Neehar Kundurti, Faculty, tulane university school of medicine
Oct 811:10
Conference pass
Harnessing AI for Smarter Drug Development
AI in Drug Development and Discovery
Joerg Degen, VP & Head of Computational Medicine, Roche
Oct 811:10
Conference pass
Approaches to precision therapeutics and clinical trial enhancements
Bioinformatics + In silico R&D
Mary Helen Black, SVP and Head of Genomics, Foresite Labs
Oct 811:10
Conference pass
LLMs inside company
Large Language Models
Robert Di Giovanni, Senior Global Patient Safety Lead, Novartis
Oct 811:10
Conference pass
Data strategy and Governance in R&D
Digital Transformation
Felipe Albrecht, Principal Scientist, pRED D&A Governance & Strategy, Roche
Oct 811:10
Conference pass
Shape a data-driven future: A Journey towards Data Integration, Data Management, and Organizational Success
Data Integration + FAIR
Oct 811:10
Conference pass
Transforming Analytics for Business Insights: From Standardization to Customization
Analytics Platform
Francesco Orsi, Data Science Manager, Roche
Oct 811:10
Conference pass
Stopping people from becoming patients - Harnessing the power of real-world data and omics to predict and pre-empt disease
Real World Evidence
Lykke Pedersen, Product Creator, Novo Nordisk
Oct 811:10
Conference pass
Unlocking the potential of cell-free RNA for liquid biopsy biomarker and diagnostics
Precision Medicine, Diagnostics and Therapies
Bogdan Mateescu, group leader, University of Zurich
Oct 811:10
Conference pass
End to end automation of laboratory workflows
Lab Automation
Felix Stemmer, Senior Scientist II, Novartis Pharma AG
Oct 811:10
Conference pass
Demonstration of quantum utility for pharma use case
Quantum Pharma
Clément Javerzac-Galy, Professor, group leader, FHNW
Oct 811:10
Conference pass
Mastering the Jungle of Real-World Data
Start up and innovation
Berber Snoeijer, CEO, ClinLine
Oct 811:20
Conference pass
Space Biotech – Harness the uniqueness of space to develop unearthly bioproducts!
Start up and innovation
Felix Steiner, Head of Business Development, Yuri
Oct 811:30
Conference pass
FAIRifying patient registries in hemoglobinopathy research
Bioinformatics + In silico R&D
Maria Xenophontos, Lab Scientific Officer - Bioinformatician, The Cyprus Institute of Neurology and Genetics
Oct 811:30
Conference pass
Streamling AI / LLM Verification Leveraging Centralized Solutions
Large Language Models
Mario Sanger, Senior AI / NLP engineer, AstraZeneca
Oct 811:30
Conference pass
Empowering AstraZeneca R&D with Self-service Data Products
Analytics Platform
Oct 811:30
Conference pass
From Prediction to Prevention: Intercepting Tumours Before They Begin
Start up and innovation
Austin Reed, CEO, InterceptX
Oct 811:40
Conference pass
Labgears – a knowledge hub for your team
Start up and innovation
Damian Graczyk, Software Development Manager, Adamed Pharma
Oct 811:50
Conference pass
AI in Drug Development at Sevier
AI in Drug Development and Discovery
Sofia Lotfi, Senior Data Scientist, Drug Discovery, Servier
Oct 811:50
Conference pass
Scaling the impact of In Silico R&D through user adoption and democratisation
Bioinformatics + In silico R&D
Oct 811:50
Conference pass
Information grounding of LLMs using knowledge graphs and documents
Large Language Models
Nikola Milosevic, Senior Computational Scientist, Bayer
Oct 811:50
Conference pass
Progressive policies on Data and AI to enable Digital Transformation
Digital Transformation
Oct 811:50
Conference pass
Development of a System for ADC Molecular Registration
Data Integration + FAIR
Phin Chooi, Senior Scientist, AstraZeneca
Oct 811:50
Conference pass
Patient journey modelling
Real World Evidence
Petra Nathan, Global Head of Implementation Science, Boehringer Ingelheim
Oct 811:50
Conference pass
Donor derived cell free DNA to personalise immunosuppression in transplantation
Precision Medicine, Diagnostics and Therapies
Oct 811:50
Conference pass
IT Landscape and Robotics in the lab
Lab Automation
Jiayi Tong, Data Engineer, Roche
Oct 811:50
Conference pass
Applications and comparisons of pharmaceutical quantum computing
Quantum Pharma
Johannes Galatsanos, Researcher at Center of Quantum Networks, Massachusetts Institute of Technology
Oct 811:50
Conference pass
Cracking the ‘code’ in Drug Discovery – InvirtuoLabs
Start up and innovation
Gianvito Grasso, Founder and CEO, InVirtuoLabs
Oct 812:10
Conference pass
Open source drug discovery
AI in Drug Development and Discovery
Jake Chen, Endowed Professor and Founding Director, SPARC, University of Alabama at Birmingham
Oct 812:10
Conference pass
Gen AI use cases in clinical quality
Large Language Models
Ioannis Spyroglou, Associate Director, Data Science, MSD
Oct 812:10
Conference pass
Multimodal Data Assets - Optimizing Drug Development with Actionable Data Insights
Data Integration + FAIR
Oct 812:10
Conference pass
Novel methylation enrichment technologies for liquid biopsies
Precision Medicine, Diagnostics and Therapies
Oct 812:10
Conference pass
Exploring the Quantum challenges and impact in pharma
Quantum Pharma
Benoit Lelong, Head of Group Data Platform, SERVIER
Oct 812:30
Conference pass
Leveraging AI to Accelerate Drug Development Pipelines
AI in Drug Development and Discovery
Prakash Rathi, Director, R&DIT, Data Analytics and AI, AstraZeneca
Oct 812:30
Conference pass
Machine learning prediction of picomolar affinity soluble T cell receptors
Bioinformatics + In silico R&D
Oct 812:30
Conference pass
Accelerating drug discovery with an AI KG-based Research Assistant chatbot
Large Language Models
Albert Maristany, Knowledge Graph Product Lead, Astrazeneca
Oct 812:30
Conference pass
Digital Transformation through AI and data analytics
Digital Transformation
Syed Ali Shirazi, Head of Smart Factory, SANOFI
Oct 812:30
Conference pass
The Power of an R&D Unified Data Catalog with Domain Models: Accelerating Insights and Enhancing Data Governance
Data Integration + FAIR
Friederike Stoll, Data Strategy & Governance, Bayer
Stefanie Holt-Noreiks, R&D Data Operations, Bayer AG
Oct 812:30
Conference pass
OCEAN: Roche’s “FAIR by Design” Analysis Platform Journey (SCE, CDR)
Analytics Platform
Ian Healy, Global Platforms Lead, Roche
Oct 812:30
Conference pass
Leveraging AI to transform social media content into real-world patient experience data
Real World Evidence
Matthias Hartung, Data & AI Expert, Boehringer Ingelheim Pharma GmbH
Oct 812:30
Conference pass
Precision anti-cancer agents, from checkpoint inhibitors to novel targeted therapies
Precision Medicine, Diagnostics and Therapies
Oct 812:30
Conference pass
Pitfalls on your way to successful lab automation and digitalisation
Lab Automation
Susanne Weissenborn, Team leader Enabling Technologies, Roche
Oct 812:30
Conference pass
Marama Labs - Breaking bottlenecks in chemical analysis of complex liquid
Start up and innovation
Brendan Darby, CEO, Marama Labs
Oct 813:20
Conference pass
Closing keynote panel: Future of AI & technologies in Neurological disorders
Keynotes
Amit Khanna, VP, Global Program HeadParkinson’s & Neuroscience Digital Programs, Novartis
Cristina Granziera, Professor, Neurology and Biomedical Engineering, University of Basel
Nikita Popov, Head AI Strategy Office, Novartis
last published: 08/Jul/25 15:55 GMT
Get involved at BioTechX
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events